Daily oral cannabis for cancer patients with solid tumors
Part of Cancer, Pain clinical trials.
This trial tests whether taking a daily oral cannabis (marijuana) dose is safe for people with advanced solid tumors (cancer that has spread). It's looking for people who are already on a stable cancer treatment and want to see if adding cannabis affects their symptoms or how they feel.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor that has spread to nearby or distant parts of the body (locally advanced or metastatic). This can be a new diagnosis or one you are already being treated for.
- You are currently on cancer treatment (like chemotherapy or targeted therapy) and have been on that same treatment for at least one month.
- You are 18 years or older.
- You have not used any cannabis (marijuana, THC, or CBD oil, including over-the-counter products) in the past 30 days.
- You are not taking checkpoint inhibitors (like Keytruda or Opdivo) or any experimental drugs.
- You do not have a history of seizures, epilepsy, or certain heart conditions, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cannabis affects symptoms in cancer patients who are getting immunotherapy. It may help understand if cannabis can improve pain and quality of life during treatment.
This study looks at how cannabis affects pain and daily life in Black and white patients with solid tumors. It compares people who use cannabis at least once a week to those who don't use it at all.
This study observes how people with cancer who use cannabis track their use with a smartphone app. It aims to understand patterns and effects without testing any new treatment.
This early-phase study tests whether a cannabinoid medicine (including nabilone/cannabis-based treatment) can be given safely to children and teens with relapsed or refractory cancer. It may help with treatment options for children whose cancer has come back or did not respond to standard therapy.
This study tests a cannabis-based extract to help control symptoms like pain, nausea, and anxiety in people with advanced cancer who are already on strong pain medication. It aims to improve your quality of life during treatment.
This study looks at the benefits and risks of using cannabis or cannabinoids for cancer patients. It aims to help understand how these products affect symptoms and quality of life during chemotherapy or immunotherapy.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.